Method for enhancing contrast produced by MRI
    2.
    发明申请
    Method for enhancing contrast produced by MRI 审中-公开
    增强MRI产生的对比度的方法

    公开(公告)号:US20080167549A1

    公开(公告)日:2008-07-10

    申请号:US12002553

    申请日:2007-12-17

    IPC分类号: A61B5/055

    摘要: A method for obtaining an image by MRI, comprising: administering at least one contrast agent to a subject in amounts effective to perform CEDST MRI analysis; and performing CEDST MRI analysis to produce an image of the subject. A number of different contrast agents can be used to practice the present method including, without limitation, sugars, amino acids, nitrogen-containing heterocycles, purines and pyrimidines, nucleosides; imidazole and derivatives thereof, imino acids, barbituric acid and analogs thereof, and miscellaneous materials, such as guanidine hydantoin, parabanic acid, and biologically active salts thereof.

    摘要翻译: 一种用于通过MRI获得图像的方法,包括:以有效执行CEDST MRI分析的量向对象施用至少一种造影剂; 并进行CEDST MRI分析以产生受试者的图像。 可以使用许多不同的造影剂来实施本发明的方法,包括但不限于糖,氨基酸,含氮杂环,嘌呤和嘧啶,核苷; 咪唑及其衍生物,亚氨基酸,巴比妥酸及其类似物,以及其它各种材料,例如胍乙内酰脲,对乙酰苯胺和其生物活性盐。

    Method for enhancing contrast produced by MRI
    3.
    发明授权
    Method for enhancing contrast produced by MRI 失效
    增强MRI产生的对比度的方法

    公开(公告)号:US06963769B1

    公开(公告)日:2005-11-08

    申请号:US09959138

    申请日:2000-04-20

    摘要: A method for obtaining an image by MRI, comprising: administering at least one contrast agent to a subject in amounts effective to perform CEDST MRI analysis; and performing CEDST MRI analysis to produce an image of the subject. A number of different contast agents can be used to practice the present method including, without limitation, sugars, animo acids, nitrogen-containing heterocycles, purines and pyrimidines, nucleosides; imidazole and derivatives thereof, imino acids, barbituric acid and analogs thereof, and miscellaneous materials, such as guanidine hydantoin, parabanic acid, and biologically active salts thereof.

    摘要翻译: 一种用于通过MRI获得图像的方法,包括:以有效执行CEDST MRI分析的量向对象施用至少一种造影剂; 并进行CEDST MRI分析以产生受试者的图像。 许多不同的耐受剂可用于实施本发明的方法,包括但不限于糖,阿莫西酸,含氮杂环,嘌呤和嘧啶,核苷; 咪唑及其衍生物,亚氨基酸,巴比妥酸及其类似物,以及其它各种材料,例如胍乙内酰脲,对乙酰苯胺和其生物活性盐。